Skip Navigation



Rheumatology Advance Access published online on January 20, 2004

Rheumatology, doi:10.1093/rheumatology/keh087
Rheumatology © British Society for Rheumatology 2004; all rights reserved
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
43/4/505    most recent
keh087v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sulli, A.
Right arrow Articles by Indiveri, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sulli, A.
Right arrow Articles by Indiveri, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Rheumatology © British Society for Rheumatology 2004; all rights reserved

Original Papers

Blunted coronary flow reserve in systemic sclerosis

A. Sulli 1*, M. Ghio 2, G. P. Bezante 3, L. Deferrari 3, C. Craviotto 1, V. Sebastiani 3, M. Setti 2, A. Barsotti 3, M. Cutolo 1, and F. Indiveri 2

1 Division of Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy
2 Division of Immunology and Internal Medicine, Department of Internal Medicine, University of Genova, Genova, Italy
3 Division of Cardiology, Department of Internal Medicine, University of Genova, Genova, Italy

* Corresponding author. E-mail: albertosulli{at}unige.it.

Received 19 August 2003 ; revised 31 October 2003

Abstract

Objectives. We investigated whether the non-invasive determination of coronary flow reserve (CFR), as evaluated by transthoracic Doppler echocardiography, might be a potential method to detect early dysfunction of cardiovascular system in patients affected by systemic sclerosis (SSc) without clinical signs or symptoms of cardiac impairment. The possible correlations between the CFR values and the duration of the disease, specific autoantibodies and cutaneous involvement subsets were investigated.

Methods. Forty-four consecutive patients affected by SSc were analysed. The CFR was detected in the distal left anterior descending coronary artery by contrast-enhanced transthoracic second harmonic Doppler in all SSc patients and in 16 healthy controls. CFR was assessed at rest and during hyperaemia induced by administration of adenosine at 0.14 mg/kg/min over 5 min. The CFR was calculated as the ratio between hyperaemic (peak adenosine infusion) and resting peak diastolic velocity (PdvCFR) and resting velocity time integral (VtiCFR). Past medical history was carefully investigated.

Results. Both PdvCFR and VtiCFR were significantly reduced in SSc patients when compared with controls (P<0.0001). In particular, both PdvCFR and VtiCFR were significantly lower in patients with dSSc when compared with patients affected by lSSc (P<0.02 and P<0.04 respectively). No statistically significant correlation was found between CFR values and history of smoking, serum levels of cholesterol or triglycerides, blood pressure, age of patients, duration of SSc and serum autoantibody positivity for ANA, ACA and Scl70.

Conclusions. CFR is often reduced in SSc patients. CFR was lower in patients with dSSc than in those affected by lSSc. A reduced CFR value should be considered an indirect sign of heart involvement in scleroderma, but its clinical and prognostic implications need to be clarified.

Key words: Systemic sclerosis, Coronary flow reserve, Heart disease, Doppler echocardiography.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
L. Belloli, N. Carlo-Stella, G. Ciocia, A. Chiti, M. Massarotti, and B. Marasini
Myocardial involvement in systemic sclerosis
Rheumatology, July 1, 2008; 47(7): 1070 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. Szucs, O. Timar, Z. Szekanecz, H. Der, G. Kerekes, S. Szamosi, Y. Shoenfeld, G. Szegedi, and P. Soltesz
Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications
Rheumatology, May 1, 2007; 46(5): 759 - 762.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. Kahan and Y. Allanore
Primary myocardial involvement in systemic sclerosis
Rheumatology, October 1, 2006; 45(suppl_4): iv14 - iv17.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.